Mehmet Altan

Dr. Mehmet Altan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AGALPER GÖK
ALPER GÖK
MAMehmet Altan
Mehmet Altan
ADAhmet Emin Dogan
Ahmet Emin Dogan
AEAşır Eraslan
Aşır Eraslan
FUFahrettin Şamil Uysal
Fahrettin Şamil Uysal
MIMuhammet Abdurrahim İmamoğlu
Muhammet Abdurrahim İmamoğlu
Background: Some studies have shown that there may be an increase in the frequency of erectile dysfunction after COVID-19. However, no long-term study has investigated whether this is permanent or temporary. In this study, we aimed to examine whether there was an increase in the frequency of erectile dysfunction among individuals with a history of COVID-19, and, if there was, whether their condition improved over time. Materials and methods: In this study, a total of 125 healthy male healthcare workers, 95 with and 30 without a history of COVID-19, were evaluated in terms of erectile function. Four study groups were formed. The first three groups consisted of individuals with a history of COVID-19 confirmed by the polymerase chain reaction (PCR) test at different times, who recovered from the disease (time elapsed since COVID-19 positivity: 12 months for Group 3). The individuals in Group 4 did not have a history of COVID-19 diagnosis. In order to evaluate the erectile function of the participants, they were asked to complete the five-item International Index of Erectile Function questionnaire (IIEF-5). Then, statistical analyses were performed to evaluate whether there was a difference between the groups in terms of the IIEF-5 scores. Results: There was a statistically significant difference between the groups in terms of the IIEF-5 scores (p < 0.001), and this difference was determined to be caused by the significantly higher IIEF-5 scores of Groups 3 and 4 compared to Group 1 (p = 0.004 and p < 0.001, respectively). In addition, the IIEF-5 score of Group 4 was statistically significantly higher than that of Group 2 (p < 0.001). However, the IIEF-5 scores did not statistically significantly differ between Groups 1 and 2, Groups 2 and 3, and Groups 3 and 4 (p > 0.999, p = 0.204, and p = 0.592, respectively). Conclusion: There may be deterioration in erectile function after COVID-19; however, this tends to improve over time, especially from the first year after active infection. Given that vascular, hormonal, and/or psychogenic factors may lead to the development of erectile dysfunction after COVID-19, we consider that in order to easily manage this process, it is important to determine the underlying cause, initiate appropriate treatment, and inform couples that this situation can be temporary.

1 September 2022 in Urology Research and Practice
Verified
Journal Article
Open access
AGAbdullah Gürel
Abdullah Gürel
BBBurhan Baylan
Burhan Baylan
IKIbrahim Keles
Ibrahim Keles
ADArif Demirbas
Arif Demirbas
MKMustafa Karalar
Mustafa Karalar
AMAhmet Yaser Müslümanoğlu
Ahmet Yaser Müslümanoğlu
Objective: The present study examines the effects of the coronavirus disease 2019 pandemic on radical prostatectomy performed as part of localized prostate cancer treatment in Turkey. Material and methods: A retrospective analysis was made of the data of 176 patients from 8 centers in Turkey who underwent radical prostatectomy due to localized prostate cancer over the 2 years spanning March 1, 2019, to February 28, 2021. Within this timeframe, March 1, 2019, to February 28, 2020, was denoted the 1-year pre-coronavirus disease 2019 period, while March 1, 2020, to February 28, 2021, was denoted the 1-year coronavirus disease 2019 period. An analysis was made of whether there was a difference in the number of radical prostatectomies performed for prostate cancer, the time from biopsy to operation, and the biopsy and radical prostatectomy pathology between the 2 periods. Results: It was found that the number of radical prostatectomies performed for localized prostate cancer during the coronavirus disease 2019 pandemic was statistically and highly significantly fewer than in the pre-coronavirus disease 2019 period (P <.001). The patients diagnosed with Gleason 3+3 (low risk) prostate cancer were statistically significantly fewer in number in the coronavirus disease 2019 period (P <.001). The pathological Gleason score was upgrading than the biopsy Gleason score in all patients who underwent in both periods (P <.001). When the periods were compared, the pathological involvement determined by lymph node dissection performed during radical prostatectomy was found to be decreased in the coronavirus disease 2019 period, although the difference was not statistically significant (P =.051). Conclusion: As with many diseases, the diagnosis and treatment of prostate cancer have been adversely affected by the coronavirus disease 2019 pandemic. Cite this article as: Gurel A, Baylan B, Keles I, et al. Effect of the COVID-19 pandemic on radical prostatectomy: A Turkish multicenter study. Turk J Urol. 2022;48(5):339-345.

13 December 2022 in Üroonkoloji Bülteni
Verified
Journal Article
Closed access
AGAbdullah Gürel
Abdullah Gürel
BBBurhan Baylan
Burhan Baylan
AÖAta Özen
Ata Özen
İKİbrahim Keleş
İbrahim Keleş
ÜÖÜnal Öztekin
Ünal Öztekin
MKMert Ali Karadag
Mert Ali Karadag

13 February 2026 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
ADAhmet Emin Dogan
Ahmet Emin Dogan
GÖGörkem Özenç
Görkem Özenç
IUIbrahim Untan
Ibrahim Untan
MAMehmet Altan
Mehmet Altan
MYMetin Yığman
Metin Yığman
HSHilmi Sarı
Hilmi Sarı
In the contemporary era, acquiring online information has become a prevalent practice. As with any affliction, individuals are inclined to investigate the potential therapeutic avenues for erectile dysfunction (ED) on the internet. To evaluate the quality, comprehensibility and informative content of YouTube videos on penile prosthesis implantation, with a focus on videos produced by healthcare professionals, and to address the videos according to the class of physician producing the video. A search for "penile prosthesis" was conducted on YouTube using a censored network to ensure privacy and prevent bias. The first 100 relevant videos uploaded in the last decade were analyzed. They were categorized by source (academicians, government or private hospital physicians, and non-physicians) and assessed for quality using the modified Quality Criteria for Consumer Health Information (DISCERN) scale, Global Quality Scale (GQS) and a newly developed Total Informative Score based on the European Association of Urology Patient Information Forms. The Kruskal-Wallis H test, Kendall's tau correlation test and Spearman's test were used for statistical analysis. Of the videos analyzed, 87% provided informative content, with the majority (51%) uploaded by academic sources. The median duration time was 185 s (111-397). The average modified DISCERN score was low (median: 2, Q1-Q3: 2-3), indicating generally inadequate quality, with 54% rated as poor. No statistical significance occurred between GQS scores for the videos published by the upload source. Videos by government hospital physicians scored the highest in quality measures, while non-physician videos garnered more views and likes. The Patient Education Materials Assessment Tool (PEMAT) understandability and actionability scores showed that videos from healthcare professionals had higher understandability (70%) than those from other sources. The overall quality of YouTube videos on penile prostheses is low, despite most being informative. Videos created by physicians are more reliable and easier to understand. Implementing stricter guidelines for content creators and promoting public awareness initiatives are recommended to improve patient access to high-quality information.

14 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
MAMehmet Altan
Mehmet Altan
ADAhmet Emin Dogan
Ahmet Emin Dogan
FSFatih SANDIKÇI
Fatih SANDIKÇI
SCSertac Cimen
Sertac Cimen
Objective: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is an important public health problem that mainly affects middle-aged female patients. Diagnosis of IC/BPS is difficult as there is no disease-specific diagnostic test. Our study analyzed the hematological parameters in female patients with IC/BPS to determine whether these parameters could assist in diagnosing IC/BPS and investigate the relationship between these parameters and disease severity. Methods: Fifty female patients with IC/BPS (i.e., patient group) and 50 healthy volunteers (i.e., control group) with no systemic diseases or complaints were included. The patients' O'Leary Sant Interstitial Cystitis Symptom Index (ICSI) scores were recorded at diagnosis. Blood neutrophil, lymphocyte, platelet counts, mean platelet volumes (MPV), neutrophil/lymphocyte (NLR), and platelet/lymphocyte ratios (PLR) were recorded and calculated based on the complete blood count results obtained during the initial outpatient clinic encounters. Patients and healthy volunteers were compared regarding age, neutrophil, lymphocyte, platelet counts, and MPV, NLR, and PLR values. The correlation between laboratory parameters and ICSI levels of the cases in the patient group was also analyzed. Results: The demographic data of the groups were similar. There was no significant difference between the groups regarding neutrophil, lymphocyte, platelet counts, and MPV levels. On the other hand, the median NLR values were significantly higher in the patient group compared to the control group (2.34 vs. 1.85, p<0.001). In the patient group, the lymphocyte count was significantly higher in the group with an ICSI score≥14 compared to the group with an ICSI score<14 (median, 1.90 vs. 1.62, p=0.009). Conclusion: Our study found that NLR was higher in IC/BPS patients than in healthy individuals and that lymphocyte counts might be associated with disease severity. Thus, hematological parameters can provide clinicians with valuable insights regarding IC/BPS disease severity and aid treatment planning.

2 November 2026 in Urology Research and Practice
Verified
Journal Article
Open access
PDF file
BEBerk Yasin Ekenci
Berk Yasin Ekenci
MAMehmet Altan
Mehmet Altan
Objective: The aim of this study was to compare clinical accuracy, response quality, and citation characteristics of ChatGPT-generated testicular cancer information across 2 assessments 20 months apart. Methods: Sixty-one patient-oriented questions derived from European Association of Urology (EAU) Patient Information were submitted to ChatGPT-4o in December 2024 and repeated unchanged using ChatGPT-5.6 Luna in August 2026. Two urologists independently assessed accuracy against contemporaneous EAU guidelines and rated quality using the Global Quality Score (GQS) and modified DISCERN (mDISCERN). Citation quantity, source quality, and source-to-claim support were evaluated. Only the first response was retained; repeated-generation variability was not assessed. Results: Fully accurate responses were 86.9% (53/61) in 2024 and 93.4% (57/61) in 2026 (P = .125). Of 8 clinically relevant inaccuracies in 2024, 4 were corrected, 3 improved but remained misleading, and 1 persisted. GQS increased from 3.75 ± 0.77 to 4.82 ± 0.41 and mDISCERN from 30.37 ± 4.65 to 36.80 ± 1.93 (both P < .001). Citations per response decreased from 5.97 ± 3.53 to 4.79 ± 1.19 (P = .042), while high-quality unique sources increased from 77.4% to 96.9% (P < .001). Fully supported sources were 80.1% and 86.4% (P = .050); 6 sources (2.6%) in 2026 did not support the claims. Conclusion: Response quality and the use of high-quality sources were greater in 2026, whereas changes in clinical accuracy and source-to-claim support were less clear. Clinically meaningful errors persisted in guideline-sensitive topics. Because different model versions and interfaces were assessed, the findings represent model- and interface-specific snapshots, not a controlled head-to-head comparison. Cite this article as: Ekenci BY, Altan M. Comparison of ChatGPT-generated patient information on testicular cancer across two assessment periods: Clinical accuracy, response quality, and citation support. Urol Res Pract. 2026;52, doi: 10.5152/ tud.2026.26067